Similar Items: International Myositis Assessment and Clinical Studies Guidelines for Risk‐Based Cancer Screening: An External Validation in Patients With Dermatomyositis Seen at a Metropolitan Academic Center
- Performance and potential impact of the IMACS cancer screening guideline in myositis: analysis in a myositis referral centre
- Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
- Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report
- Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
- Clinical Images: Skin manifestations and radiographic findings of anti‐SAE1 positive dermatomyositis
- Clinically Amyopathic Dermatomyositis: Epidemiology, Clinical Presentation, Pathophysiology, Treatment, and Prognosis: A Systematic Review